Aniracetam
Research-chemical, Nootropic
An anxiolytic nootropic which modulates the AMPA receptor. Significantly more potent than racetam. May have positive effects on memory and cognition. Little recreational value. Sold in Europe as a prescription drug, but not approved by the FDA in the US.
Oral: 8.6-11.4% (This is due to the extensive first pass hepatic metabolism) - Presumably higher when taken with fatty acids.
Rapid onset.
Common
Oral
1500mg
Duration
After Effects
Oral
2 to 4
1 to 4